Occam's razor suggests a short-term extension of ARPA-enhanced subsidies for Obamacare

 Note: Free xpostfactoid subscription is available on Substack alone, though I will continue to cross-post on this site. If you're not subscribed, please visit xpostfactoid on Substack and sign up.

Back in July, a memo by Trump pollster Fabrizio Ward famously forecast that refusing to extend the enhanced ACA premium subsidies established by the American Rescue Plan Act, currently funded only through 2025, would cost Republicans the House of Representatives in 2026. More than 80% of the general public supported extended the enhanced subsidies, Ward claimed. Failing to extend them would increase a generic Republican’s then-current polling deficit among motivated voters in the midterms from -8% to -15%. Extending them would swing the generic ballot to +6% among motivated voters.

Underlying that calculation are the huge premium increases that will hit the 22 million current ACA marketplace enrollees (or their 2026 prospective replacements) if the ARPA enhanced subsidies expire. According to an oft-cited KFF estimate, ARPA subsidy expiration would lead to an average increase of 75%* in premiums paid by marketplace enrollees — an average that rolls together reduced subsidies for those eligible, complete loss of subsidies for enrollees with income above the pre-ARPA income cap on subsidy eligibility, and average base (unsubsidized) premium increases a bit below or a bit above 20% (the higher estimate, by Charles Gaba, is weighted according to plans’ enrollment).

All Dem (and doc) hands on deck to get Medicare drug negotiation/ACA subsidy boosts across the finish line

Subscribe (free) to xpostfactoid

It struck my eye last week  that Doctors for America, a physician advocacy group that supports single-payer healthcare, saw fit to call on member docs (via email) to lobby for what's left of the Democrats' reconciliation bill:

This is a decisive week in Congress with the Senate poised to vote on several crucial pieces of legislation, including allowing the HHS Secretary to negotiate for Medicare drug pricing, out-of-pocket caps in Part D, and rebates for price increases exceeding inflation. There are also new provisions to make vaccines free for Medicare beneficiaries, to stabilize premiums, and expand the Medicare low-income subsidy programs.

We hope the Senate will move forward with a meaningful reconciliation package that includes the drug price provisions before the August recess. But we need to apply pressure to do so.  Remind your senators to choose #PatientsOverPolitics and pass the reconciliation bill this week, including all of the health care provisions promised to the American people.